Benjamin Hickey

Benjamin Hickey, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Mirati Therapeutics, Inc. and Bristol Myers Squibb Co. We count 17 filings; the first trade dates from 7 January 2022 and the latest from 27 February 2026.

Every open-market trade on record is a sale: 7 sales worth €647k. Outside the open market, there are 5 share grants and 4 option exercises.

On 3 March 2026 came the latest disclosure, an option exercise in Bristol Myers Squibb Co. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.